These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28115591)

  • 1. Type II NKT Cells and Their Emerging Role in Health and Disease.
    Dhodapkar MV; Kumar V
    J Immunol; 2017 Feb; 198(3):1015-1021. PubMed ID: 28115591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic strategies targeting natural killer T cell responses in cancer.
    Shissler SC; Bollino DR; Tiper IV; Bates JP; Derakhshandeh R; Webb TJ
    Immunogenetics; 2016 Aug; 68(8):623-38. PubMed ID: 27393665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.
    Arrenberg P; Halder R; Kumar V
    J Cell Physiol; 2009 Feb; 218(2):246-50. PubMed ID: 18814145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
    Dasgupta S; Kumar V
    Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
    Cohen NR; Garg S; Brenner MB
    Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II NKT Cells: An Elusive Population With Immunoregulatory Properties.
    Singh AK; Tripathi P; Cardell SL
    Front Immunol; 2018; 9():1969. PubMed ID: 30210505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
    Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-Specific Roles of NKT Cells in Tumor Immunity.
    Terabe M; Berzofsky JA
    Front Immunol; 2018; 9():1838. PubMed ID: 30158927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKT Cells Contribute to the Control of Microbial Infections.
    Vogt S; Mattner J
    Front Cell Infect Microbiol; 2021; 11():718350. PubMed ID: 34595131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexity and function of natural killer T cells with potential application to hepatic transplant survival.
    Ware R; Kumar V
    Liver Transpl; 2017 Dec; 23(12):1589-1592. PubMed ID: 28945950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.
    Nishioka Y; Masuda S; Tomaru U; Ishizu A
    Front Immunol; 2018; 9():548. PubMed ID: 29599785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKT-cell subsets: promoters and protectors in inflammatory liver disease.
    Kumar V
    J Hepatol; 2013 Sep; 59(3):618-20. PubMed ID: 23669283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary approaches to study NKT cells in cancer.
    Berzofsky JA; Olkhanud PB; Terabe M
    Methods Enzymol; 2020; 631():371-389. PubMed ID: 31948558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT and tolerance.
    Diana J; Beaudoin L; Gautron AS; Lehuen A
    Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
    J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
    Sundell IB; Halder R; Zhang M; Maricic I; Koka PS; Kumar V
    J Stem Cells; 2010; 5(1):33-42. PubMed ID: 20861926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immunology of CD1- and MR1-Restricted T Cells.
    Mori L; Lepore M; De Libero G
    Annu Rev Immunol; 2016 May; 34():479-510. PubMed ID: 26927205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity.
    Tiwary S; Berzofsky JA; Terabe M
    Front Immunol; 2019; 10():2187. PubMed ID: 31620124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
    Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
    Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
    Peralbo E; Alonso C; Solana R
    Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.